Valeo Financial Advisors, LLC Enanta Pharmaceuticals Inc Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$43.36 - $53.53 $18,688 - $23,071	-431 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$40.22 - $62.0 $3,016 - $4,650	-75 Reduced 14.82%	431 $22,000
Q4 2019 Jan 24, 2020	SELL	$57.95 - $66.61 $17,095 - $19,649	-295 Reduced 36.83%	506 $31,000
Q2 2019 Jul 10, 2019	SELL	$81.3 - $97.35 $2,276 - $2,725	-28 Reduced 3.38%	801 $68,000
Q1 2019 Apr 12, 2019	BUY	$69.08 - $105.66 $37,924 - $58,007	549 Added 196.07%	829 $79,000
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $10,614 - $13,104	280	280 $13,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $121M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.